The store will not work correctly when cookies are disabled.
1-(biphenyl-2-yl)-4-(3-methoxyphenethyl)piperazine
ID: ALA4207454
PubChem CID: 145976433
Max Phase: Preclinical
Molecular Formula: C25H28N2O
Molecular Weight: 372.51
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1cccc(CCN2CCN(c3ccccc3-c3ccccc3)CC2)c1
Standard InChI: InChI=1S/C25H28N2O/c1-28-23-11-7-8-21(20-23)14-15-26-16-18-27(19-17-26)25-13-6-5-12-24(25)22-9-3-2-4-10-22/h2-13,20H,14-19H2,1H3
Standard InChI Key: DIBDPOHLDFFTGB-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
5.2154 -6.1248 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2143 -6.9443 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9223 -7.3533 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6320 -6.9438 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6291 -6.1212 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9205 -5.7159 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3380 -7.3550 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.3373 -8.1732 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0416 -8.5806 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7511 -8.1744 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.7518 -7.3562 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0430 -6.9443 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4579 -8.5845 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1665 -8.1775 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8733 -8.5877 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8666 -9.4029 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5725 -9.8130 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2821 -9.4059 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2813 -8.5845 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5748 -8.1781 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9885 -8.1749 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.6967 -8.5826 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9240 -8.1683 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2145 -8.5761 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2140 -9.3925 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9221 -9.8021 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6323 -9.3893 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6294 -8.5742 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 1 0
7 12 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
4 7 1 0
10 13 1 0
13 14 1 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
19 21 1 0
21 22 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 23 1 0
3 23 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 372.51 | Molecular Weight (Monoisotopic): 372.2202 | AlogP: 4.73 | #Rotatable Bonds: 6 |
Polar Surface Area: 15.71 | Molecular Species: NEUTRAL | HBA: 3 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 8.21 | CX LogP: 5.43 | CX LogD: 4.56 |
Aromatic Rings: 3 | Heavy Atoms: 28 | QED Weighted: 0.62 | Np Likeness Score: -0.84 |
References
1. Modica MN, Lacivita E, Intagliata S, Salerno L, Romeo G, Pittalà V, Leopoldo M.. (2018) Structure-Activity Relationships and Therapeutic Potentials of 5-HT7 Receptor Ligands: An Update., 61 (19): [PMID:29767995] [10.1021/acs.jmedchem.7b01898] |